Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria · Delayed Price · Currency is NGN

6.55

-0.15 (-2.24%)

At close: Nov 4, 2026

NGX:NEIMETH Financials Overview

Financials in millions NGN. Fiscal year is January - December.

Millions NGN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
Revenue	8,369	7,369	4,485	2,210	2,919	2,703
Revenue Growth	30.76%	64.29%	102.98%	-24.31%	8.01%	-11.29%
Gross Profit	3,593	3,033	1,936	709.15	1,033	1,074
Operating Income	2,489	2,169	1,832	298.73	-12.39	-24.8
Net Income	1,025	976.42	-885.33	-1,798	-325.04	-109.66
Earnings Per Share	0.22	0.23	-0.21	-0.42	-0.17	-0.06
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
Pharmaceuticals	7,181	4,301	2,067	2,844	2,635
Animal Health	187.55	184.26	142.84	75.09	67.38
Total	7,369	4,485	2,210	2,919	2,703

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
Cash & Investments	3,370	1,555	2,147	2,429	448.37	810.49
Total Debt	9,238	9,618	5,385	4,388	3,645	3,331
Net Cash (Debt)	-5,868	-8,063	-3,238	-1,959	-3,197	-2,521
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.24	-1.89	-0.76	-0.46	-1.68	-1.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
Operating Cash Flow	1,671	1,507	396.21	-773.41	132.55	-61.76
Capital Expenditures	-749.37	-278.23	-702.92	-936.14	-1,270	-1,143
Free Cash Flow	921.82	1,229	-306.71	-1,710	-1,137	-1,205
Free Cash Flow Growth	9.28%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
Gross Margin	42.93%	41.16%	43.16%	32.09%	35.39%	39.74%
Operating Margin	29.73%	29.44%	40.84%	13.52%	-0.43%	-0.92%
Pretax Margin	16.52%	17.82%	-19.05%	-76.47%	-10.63%	-4.06%
Profit Margin	12.25%	13.25%	-19.74%	-81.35%	-11.13%	-4.06%
FCF Margin	11.01%	16.68%	-6.84%	-77.37%	-38.95%	-44.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Nov '26 Nov 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022
PE Ratio	30.22	25.38	-	-	-	-
P/FCF Ratio	34.70	20.16	-	-	-	-
PS Ratio	3.82	3.36	2.18	3.75	0.93	0.98